152 related articles for article (PubMed ID: 24387251)
1. Antineutrophil cytoplasmic antibodies in patients with Graves' disease: association of antimyeloperoxidase autoantibodies with propylthiouracil therapy.
Honda H; Shibata T; Hara H; Ban Y; Sugisaki T
Mod Rheumatol; 2003 Dec; 13(4):305-12. PubMed ID: 24387251
[TBL] [Abstract][Full Text] [Related]
2. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
Huang CN; Hsu TC; Chou HH; Tsay GJ
J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
[TBL] [Abstract][Full Text] [Related]
5. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
6. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
[TBL] [Abstract][Full Text] [Related]
7. Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies (MPO-ANCA) in childhood onset Graves' disease treated with propylthiouracil.
Fujieda M; Suzuki K; Sato H; Hattori M; Wada N; Tsuchiya M; Okamoto N; Murata T; Matsudaira M; Shimizu M; Ohta K; Naruse K; Sugihara S; Wakiguchi H
Clin Nephrol; 2005 Jun; 63(6):437-45. PubMed ID: 15960145
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole.
Wada N; Mukai M; Kohno M; Notoya A; Ito T; Yoshioka N
Endocr J; 2002 Jun; 49(3):329-34. PubMed ID: 12201217
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil.
Cin MO; Gursoy A; Morris Y; Aydintug OT; Kamel N; Gullu S
Int J Clin Pract; 2009 Feb; 63(2):299-302. PubMed ID: 19196368
[TBL] [Abstract][Full Text] [Related]
10. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis in a patient with a predisposition to autoimmune abnormalities.
Iyoda M; Kuroki A; Kato K; Shibata T; Kitazawa K; Sugisaki T
Mod Rheumatol; 2003 Jun; 13(2):173-6. PubMed ID: 24387178
[TBL] [Abstract][Full Text] [Related]
11. A successful pregnancy and delivery case of Graves' disease with myeloperoxidase antineutrophil cytoplasmic antibody induced by propylthiouracil.
Yamashita Y; Yamane K; Fujikawa R; Okubo M; Kohno N
Endocr J; 2002 Oct; 49(5):555-9. PubMed ID: 12507274
[TBL] [Abstract][Full Text] [Related]
12. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
[TBL] [Abstract][Full Text] [Related]
13. [A case of membranous nephropathy with ANCA-associated necrotizing glomerulonephritis during oral administration of PTU for Graves' disease].
Fujii T; Kawamata T; Ueda S; Akikusa B; Hasegawa S; Tsukahara T; Iesato K; Ogawa M; Saisho H
Nihon Jinzo Gakkai Shi; 2003; 45(8):771-7. PubMed ID: 14737995
[TBL] [Abstract][Full Text] [Related]
14. [Thyroid hormone autoantibodies in Hashimoto's disease and Graves' disease].
Nakamura S; Murayama M; Kojima N; Kamikubo K; Sakata S; Yasuda K; Miura K
Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1597-607. PubMed ID: 6689304
[TBL] [Abstract][Full Text] [Related]
15. [A pediatric case of myeloperoxidase-antineutrophil cytoplasmic (ANCA)-related crescentic glomerulonephritis associated with propylthiouracil treatment for Graves' disease].
Kawasaki Y; Suzuki J; Sike T; Isome M; Nozawa R; Suzuki S; Kume K; Suzuki H
Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):612-7. PubMed ID: 9893462
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
17. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
Guo XH; Zhao MH; Gao Y; Wang SF; Gao Y
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):932-5. PubMed ID: 12899790
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: report of three adult cases.
Tanemoto M; Miyakawa H; Hanai J; Yago M; Kitaoka M; Uchida S
Am J Kidney Dis; 1995 Nov; 26(5):774-80. PubMed ID: 7485130
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibodies-positive vasculitis and their target antigens: a report of 4 cases and literature review].
Xu X; Zhao M; Zhang Y; Guo X; Wang H
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):404-7. PubMed ID: 12137604
[TBL] [Abstract][Full Text] [Related]
20. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil.
Ishii R; Imaizumi M; Ide A; Sera N; Ueki I; Horie I; Ando T; Usa T; Ejima E; Ashizawa K; Eguchi K
Endocr J; 2010; 57(1):73-9. PubMed ID: 19851036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
